The company has applied to the Shenzhen Stock Exchange to withdraw certain risk warnings triggered by the controlling shareholder's fund occupation. The application was approved by the board on April 27, 2026, but is currently in the supplementary materials stage, with uncertainty regarding approval. The company will fulfill its disclosure obligations based on the progress of the application.
Summary generated by AI · Always verify with source document
Securities Code: 002872
Securities Abbreviation: ST Tiansheng
Announcement No.: 2026-034
Tiansheng Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of the information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.